AKT1 and cancer: Accumulated evidence has revealed that the activation of the PI3K/Akt/mTOR signaling pathway leads to the occurrence of malignant tumors, indicating that the targeted suppression of certain components in this pathway might be a potential therapeutic strategy for cancer treatment [11,12].